Skip to main content
SpringerLink
Log in

Pharmaceutical companies join forces on HIV

  • News
  • Published:

From Nature

View current issue Submit your manuscript

GlaxoSmithKline and Pfizer create spin-off to develop new combination drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Declan Butler
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

25 years of HIV

AIDS Special

Related external links

GSK-Pfizer HIV Futures

MSF Campaign for Access to Essential Medicines

MSF site on patent pooling of HIV drugs

Rights and permissions

Reprints and permissions

About this article

Cite this article

Butler, D. Pharmaceutical companies join forces on HIV. Nature 458, 950–951 (2009). https://doi.org/10.1038/458950b

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/458950b

  • Springer Nature Limited

Search

Navigation